An extended-release formulation of desferrioxamine for subcutaneous administration

Drug Delivery

Volumn 16, Issue 7, 2009, Pages 416-421

  Toliyat, Tayebeh ^a   Jorjani, Masomeh ^b   Khorasanirad, Zeinab ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Iron excretion

Indexed keywords

DEFEROXAMINE; IRON; LIPOSOME; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG FORMULATION; ENCAPSULATION; IRON OVERLOAD; IRON TRANSPORT; MALE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE; SUSTAINED DRUG RELEASE; TEMPERATURE DEPENDENCE; URINARY EXCRETION;

ADMINISTRATION, CUTANEOUS; ANIMALS; CHEMISTRY, PHARMACEUTICAL; DEFEROXAMINE; DELAYED-ACTION PREPARATIONS; MALE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 70449119652     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.1080/10717540903141768     Document Type: Article

References (18)

1. Ceci, A., Felisi, M., De Sanctis, V., De Mattia, D. (2003). Pharmacotherapy of iron overload in thalassaemic patients. Expert Opin Pharmacother. 4, 1763-1774
2. Ellena, J.F., Le, M., Cafiso, D., Solis, R.M., Langston, M., Sankaram, M.B. (1999). Distribution of phospholipids and triglycerides in multivesicular lipid particles. Drug Delivery. 6:97-106.
3. Gordeuk, V., Thum, P., Brittenham, G., Mclaren, C., Parry, D., Backenstose, A., Biemba, G., Msiska, R., Holmes, L., Mckinley, E., Vargas, L., Gilkson, R., Poltera, A.A. (1992). Effect of iron chelating therapy on recovery from deep coma in children with cerebral malaria. New Engl J Med. 327, 1473-1477
4. Howell, S.B. (2001). Clinical applications of a novel sustained -release injectable drug delivery system: Depofoam Technology™. Cancer J. 7, 219-227
5. Katre, N.V. (2001). Lipid-based multivesicular carries for sustained delivery of therapeutic proteins and peptides. Biopharm. 14, 8-11.
6. Katre, N.V., Asherman, J., Schaefer, H., Hora, M. (1998). Multivesicular liposome (Depofoam) technology for the sustained delivery of insulin-like growth factor-I (IGF-I). J Pharm Sci. 87, 1341-1346
7. Kim, S., Turker, M.S., Chi, E.Y., Sela, S., Martin, G.M. (1983). Preparation of multivesicular liposomes. Biochim Biophys Acta. 728, 3339-3348
8. Lanston, M.V., Ramprasad, M.P., Kararli, T.T., Galluppi, G.R., Katre, N.V. (2003). Modulation of the sustained delivery of myelopoietin (Leridistim) encapsulated in multivesicular liposomes (Depofoam). J Contr Rel. 89, 87-99.
9. Lowther, N., Sparks, K., Nicklin, J., Jin, Y. (1999). A novel depot preparation of desferrioxamine-B: development of formulation principles. Drug Dev Ind Pharm. 25, 1157-1166
10. Mabeza, G.F., Biemba, G., Gordeuk, V.R. (1996). Clinical studies of iron chelators in Malaria. Acta Haematol. 95, 78-86.
11. Mantripragada, S. (2002). A lipid based depot (Depofoam technology) for sustained release drug delivery. Prog Lipid Res. 41, 392-406.
12. Porter, J.B. (1997). A risk-benefit assessment of iron-chelation therapy. Drug Saf. 17, 407-421
13. Ramprasad, M.P., Amini, A., Kararli, T., Katre, N.V. (2003). The sustained granulopoietic effect of progenipoietrin encapsulated in multivesicular liposomes. Int J Pharm. 261, 93-103. (Pubitemid 36962748)
14. Schlicher, E.J.A.M., Postma, N.S., Zuidema, J., Talsma, H., Hennink, W.E. (1997). Preparation and characterization of poly (D,L-lactic-co-glycolic acid) microspheres containing desferrioxamine. Int J Pharm. 153, 235-245
15. Schnebli, H.P., Hassan, I., Hamilton, K.O., Lynch, S., Jin, Y., Nick, H.P., Peter, H.H., Junker-Walker, U., Ziel, R., Khanna, S.C., Dean, R., Bergeron, R.J. (1994). Toward better chelation therapy: current concepts and research strategy. In: Bergeron RJ, Brittenham GM, editors. The development of iron chelators for clinical use. Boca Raton, FL: CRC Press. pp 131-149.
16. Traore, O., Carnevale, P., Kaptue-Noche, L., Bede, J.M., Desfontaine, M., Elion, J., Labie, D., Nagel, R.L. (1991). Preliminary report on the use of desferrioamine in the treatment of plasmodium faliparum malaria. Am J Hematol. 37, 206-208
17. US Pharmacopeia 26. (2003). US Pharmacopial Convention. Rockville, MD, 546.
18. Ye, Q., Asherman, J., Stevenson, M., Brownson, E., Katre, N.Y. (2000). Depofoam technology: a vehicle for controlled delivery of protein and peptide drugs. J Contr Rel. 64, 155-166